NEW YORK (GenomeWeb News) — Integrated Genomics yesterday said it has partnered with Coda Genomics to offer combined services for optimizing protein expression in humans, plants, and viruses.
IG said the collaboration creates an optimized protocol that uses its Pichia yeast-expression system with Coda translational protein expression.
“We provide the informatics, and Coda provides the methodology for optimization,” Vinayak Kapatral, IG’s vice president of business development. Kapatral, told GenomeWeb News.
He said IG will market the protocol, which clients can use on-site or can lease for their own use.
IG CEO and President John Elling said that coupling his company’s genomics sequences for Pichia and other cell lines technology with Coda’s translation engineering will “help increase yield and activity of difficult to express proteins.”
Financial terms of the agreement were not released.